guest ::
| Home > Publications database > Vitamin D supplementation, cancer incidence and mortality: Randomized trials revisited. |
| Home > Publications database > Vitamin D supplementation, cancer incidence and mortality: Randomized trials revisited. |
| Journal Article | DKFZ-2026-02815 |
; ; ; ;
2026
Elsevier
Amsterdam [u.a.]
Abstract: Vitamin D insufficiency and deficiency are highly prevalent among older adults globally and have been associated with increased cancer mortality in observational studies. Large randomized trials (VITAL and D-Health) found no reductions in cancer incidence or mortality with vitamin D supplementation but included mostly vitamin D-sufficient populations.Using UK Biobank (UKB) data, we conducted analyses informed by the VITAL and D-Health designs, applying their eligibility criteria and assuming the serum 25-hydroxyvitamin D (25(OH)D) increases observed in the trials (30 and 38 nmol/L, respectively). Populations meeting the trial criteria were weighted to match the trial baseline 25(OH)D distributions. To emulate alternative targeted interventions, analyses were restricted to vitamin D-insufficient or -deficient individuals (25(OH)D < 50 or < 30 nmol/L, respectively). Multivariable Cox models estimated associations per 30 or 38 nmol/L higher baseline 25(OH)D concentration over the corresponding trial follow-up periods.In analyses reflecting the original VITAL or D-Health 25(OH)D distributions, no association with cancer incidence or mortality was observed for the 25(OH)D increases achieved in the trials. However, inverse associations with cancer mortality were observed among vitamin D-insufficient and -deficient individuals, with hazard ratios (95% confidence intervals) of 0.93 (0.86-1.02) and 0.87 (0.77-0.97) in the VITAL-type cohort, and 0.92 (0.85-0.99) and 0.87 (0.80-0.96) in the D-Health-type cohort.Increases in 25(OH)D concentrations achieved in the trials were associated with substantially lower cancer mortality among vitamin D-insufficient and -deficient individuals. Null effects on cancer incidence and mortality observed in the trials were to be expected given the lack of associations between 25(OH)D and these outcomes among vitamin D replete populations.
Keyword(s): Cancer incidence ; Cancer mortality ; Dose-response ; Hazard ratio ; Observational study ; Randomized controlled trials ; Vitamin D
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; Nationallizenz
; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
